Isocitrate Dehydrogenase Gene Mutation clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in subjects with advanced relapsed, refractory, or resistant hematological malignancies that harbor IDH mutations.
Orange, California and other locations